Back to Search

A Phase 1/2 Study of Avutometinib (VS-6766) in Combination With Sotorasib in Patients With KRAS G12C Mutant Non-Small Cell Lung Cancer (NSCLC)

  • Protocol Number: 202204039
  • Principal Investigator: Govindan, Ramaswamy
  • Cancer Types: Lung

Learn more about this study at: clinicaltrials.gov

For more information on this trial, contact us here:

Phone
800-600-3606
Email
info@ccadmin.wustl.edu

Brief Summary

This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with sotorasib in patients with G12C Non-Small Cell Lung Cancer (NSCLC) in patients who have been exposed to prior G12C inhibitor and those who have not been exposed to prior G12C inhibitor.

Protocol Interventions

avutometinib (VS-6766) and sotorasib